Best Targeted Therapy Treatment Hospitals Worldwide

With advanced oncology infrastructure, Prince Court Medical Centre offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2007, the MSQH accredited hospital is located in Kuala Lumpur, Malaysia, and has 277 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

The state-of-the-art Targeted Therapy services offered by BLK-Max Super Speciality Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Delhi, India. Founded in 1959, the JCI, NABH accredited hospital has 650 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

Parkway Pantai aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI, MSQH accredited hospital was established in 1974 in Kuala Lumpur, Malaysia and has 499 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Artemis Health Institute, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI, NABH accredited facility has been functioning since 2007 and is located in Gurgaon, India. The hospital has 750 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by Sunway Medical Centre, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Kuala Lumpur, Malaysia. Founded in 1999, the ACHS accredited hospital has 724 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Bangpakok 9 International Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI, GHA accredited facility has been functioning since 2003 and is located in Bangkok, Thailand. The hospital has 300 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Medipol Bahçelievler Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2022 and is located in Istanbul, Turkey. The hospital has 441 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by Medanta - The Medicity, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Gurgaon, India. Founded in 2009, the JCI, NABH accredited hospital has 1250 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

With advanced oncology infrastructure, ParkCity Medical Centre offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2012, the JCI accredited hospital is located in Kuala Lumpur, Malaysia, and has 300 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At Gleneagles Hospital Mumbai, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 1996, the JCI accredited hospital is located in Mumbai, India, and has 450 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Subang Jaya Medical Centre, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 1985, the JCI accredited hospital is located in Kuala Lumpur, Malaysia, and has 442 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Max Super Specialty Hospital, Vaishali, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The NABL, NABH accredited facility has been functioning since 2008 and is located in Ghaziabad, India. The hospital has 370 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

With advanced oncology infrastructure, Max Hospital, Gurgaon offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2007, the ISO, NABH, NABL accredited hospital is located in Gurgaon, India, and has 104 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

Indraprastha Apollo Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 1996 in Delhi, India and has 710 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Apollo Hospitals, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 1988, the JCI accredited hospital is located in Hyderabad, India, and has 550 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.